This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
S100 protein
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | |||
<StructureSection load='2rgi' size='350' side='right' scene='' caption='Human S-100A2 complex with isopropanol and Na+ ion (PDB code [[2rgi]])'> | <StructureSection load='2rgi' size='350' side='right' scene='' caption='Human S-100A2 complex with isopropanol and Na+ ion (PDB code [[2rgi]])'> | ||
== Function == | == Function == | ||
| Line 41: | Line 40: | ||
**[[2k2f]] – rCBP-1 + Ca + ryanodine receptor peptide - NMR<br /> | **[[2k2f]] – rCBP-1 + Ca + ryanodine receptor peptide - NMR<br /> | ||
**[[2kbm]] – rCBP-1 + F-actin capping protein peptide - NMR<br /> | **[[2kbm]] – rCBP-1 + F-actin capping protein peptide - NMR<br /> | ||
| - | **[[1zfs]], [[2lp2]] – hCBP-1 + Ca – human - NMR<br /> | + | **[[1zfs]], [[2lp2]], [[2lp3]], [[2l0p]] – hCBP-1 + Ca – human - NMR<br /> |
| - | **[[ | + | **[[5k89]] – hCBP-1 + Ca <br /> |
**[[2lux]] - hCBP-1 (mutant) + Ca - NMR<br /> | **[[2lux]] - hCBP-1 (mutant) + Ca - NMR<br /> | ||
**[[2lhl]], [[2lls]], [[2m3w]] – hCBP-1 (mutant) - NMR<br /> | **[[2lhl]], [[2lls]], [[2m3w]] – hCBP-1 (mutant) - NMR<br /> | ||
| Line 64: | Line 63: | ||
**[[3c1v]], [[3cga]], [[3ko0]], [[4hsz]] – hCBP-4 + Ca <br /> | **[[3c1v]], [[3cga]], [[3ko0]], [[4hsz]] – hCBP-4 + Ca <br /> | ||
**[[3m0w]] – hCBP-4 + Ca + PCP<br /> | **[[3m0w]] – hCBP-4 + Ca + PCP<br /> | ||
| + | **[[5lpu]] – hCBP-4 + Ca + annexin A2<br /> | ||
**[[3zwh]], [[4cfq]], [[4cfr]] – hCBP-4 (mutant) + Ca + myosin-9 peptide<br /> | **[[3zwh]], [[4cfq]], [[4cfr]] – hCBP-4 (mutant) + Ca + myosin-9 peptide<br /> | ||
**[[4eto]] – hCBP-4 + Ca + myosin-9 peptide<br /> | **[[4eto]] – hCBP-4 + Ca + myosin-9 peptide<br /> | ||
| Line 81: | Line 81: | ||
**[[1k96]], [[1k9k]] – hCBP-6 + Ca <br /> | **[[1k96]], [[1k9k]] – hCBP-6 + Ca <br /> | ||
**[[2m1k]] – hCBP-6 (mutant) + RAGE receptor - NMR <br /> | **[[2m1k]] – hCBP-6 (mutant) + RAGE receptor - NMR <br /> | ||
| - | **[[4p2y]] – hCBP-6 + RAGE receptor + Ca + Zn <br /> | + | **[[4p2y]], [[4ybh]] – hCBP-6 + RAGE receptor + Ca + Zn <br /> |
*S100-A7 (Psoriasin) | *S100-A7 (Psoriasin) | ||
| Line 93: | Line 93: | ||
**[[1mr8]] – hCBP-8 + Ca <br /> | **[[1mr8]] – hCBP-8 + Ca <br /> | ||
| - | **[[ | + | **[[5hlo]], [[5hlv]] – hCBP-8 + Ca + Zn <br /> |
| - | **[[1xk4]] – hCBP-8 (mutant) | + | **[[1xk4]] – hCBP-8 (mutant) + hCBP-9 (mutant) + Ca <br /> |
**[[4ggf]] – hCBP-8 + hCBP-9 + Ca + Mn <br /> | **[[4ggf]] – hCBP-8 + hCBP-9 + Ca + Mn <br /> | ||
| - | **[[ | + | **[[5w1f]] – hCBP-8 (mutant) + hCBP-9 (mutant) + Ni + Ca <br /> |
| + | **[[4xjk]] – hCBP-8 (mutant) + hCBP-9 (mutant) + Ca + Mn <br /> | ||
| + | |||
*S100-A9 (Calgranulin-B or Migration inhibitory factor-related protein 14) | *S100-A9 (Calgranulin-B or Migration inhibitory factor-related protein 14) | ||
**[[1xk4]] – hCPB-9 (mutant) + hCBP-8 (mutant) + Ca <br /> | **[[1xk4]] – hCPB-9 (mutant) + hCBP-8 (mutant) + Ca <br /> | ||
| - | **[[ | + | **[[5i8n]] – hCPB-9 (mutant) - NMR <br /> |
**[[1irj]] – hCBP-9 + Ca <br /> | **[[1irj]] – hCBP-9 + Ca <br /> | ||
| Line 169: | Line 171: | ||
**[[1mho]], [[3cr4]], [[3gk1]], [[3gk2]], [[3gk4]], [[3iqo]], [[3lk0]], [[3lk1]], [[3lle]], [[3rlz]] – bCBP + Ca <br /> | **[[1mho]], [[3cr4]], [[3gk1]], [[3gk2]], [[3gk4]], [[3iqo]], [[3lk0]], [[3lk1]], [[3lle]], [[3rlz]] – bCBP + Ca <br /> | ||
**[[3cr2]], [[3cr5]] – bCBP + Zn + Ca <br /> | **[[3cr2]], [[3cr5]] – bCBP + Zn + Ca <br /> | ||
| - | **[[4pdz]], [[4pe0]], [[4pe1]], [[4pe4]], [[4pe7]] – bCBP + Ca + inhibitor<br /> | + | **[[4pdz]], [[4pe0]], [[4pe1]], [[4pe4]], [[4pe7]], [[5dkn]], [[5dkq]], [[5dkr]], [[5er4]], [[5er5]] – bCBP + Ca + inhibitor<br /> |
**[[4fqo]] – bCBP (mutant) + Ca + inhibitor<br /> | **[[4fqo]] – bCBP (mutant) + Ca + inhibitor<br /> | ||
**[[1uwo]], [[2pru]] – hCBP - NMR <br /> | **[[1uwo]], [[2pru]] – hCBP - NMR <br /> | ||
**[[2h61]], [[3hcm]] – hCBP + Ca <br /> | **[[2h61]], [[3hcm]] – hCBP + Ca <br /> | ||
| - | **[[4xyn]] – hCBP + Ca + RAGE peptide <br /> | + | **[[4xyn]], [[5d7f]] – hCBP + Ca + RAGE peptide <br /> |
**[[3czt]], [[3d0y]], [[3d10]] – hCBP + Zn + Ca <br /> | **[[3czt]], [[3d0y]], [[3d10]] – hCBP + Zn + Ca <br /> | ||
**[[2m49]] – hCBP + fibroblast growth factor 2 - NMR<br /> | **[[2m49]] – hCBP + fibroblast growth factor 2 - NMR<br /> | ||
| + | **[[5csi]], [[5csj]], [[5csn]], [[5csf]] – hCBP subunit β + ribosomal protein S6 kinase α-1 peptide + Ca <br /> | ||
*Calbindin D9k (S100G) | *Calbindin D9k (S100G) | ||
| Line 204: | Line 207: | ||
**[[2y5i]] – CBP + Ca - zebrafish <br /> | **[[2y5i]] – CBP + Ca - zebrafish <br /> | ||
| + | **[[5hyd]] – hCBP <br /> | ||
}} | }} | ||
== References == | == References == | ||
Revision as of 19:51, 2 October 2017
| |||||||||||
3D Structures of S100 proteins
Updated on 02-October-2017
References
- ↑ Donato R, Cannon BR, Sorci G, Riuzzi F, Hsu K, Weber DJ, Geczy CL. Functions of S100 proteins. Curr Mol Med. 2013 Jan;13(1):24-57. PMID:22834835
- ↑ Yao R, Lopez-Beltran A, Maclennan GT, Montironi R, Eble JN, Cheng L. Expression of S100 protein family members in the pathogenesis of bladder tumors. Anticancer Res. 2007 Sep-Oct;27(5A):3051-8. PMID:17970044
- ↑ Wilsmann-Theis D, Wagenpfeil J, Holzinger D, Roth J, Koch S, Schnautz S, Bieber T, Wenzel J. Among the S100 proteins, S100A12 is the most significant marker for psoriasis disease activity. J Eur Acad Dermatol Venereol. 2016 Jul;30(7):1165-70. doi: 10.1111/jdv.13269., Epub 2015 Sep 2. PMID:26333514 doi:http://dx.doi.org/10.1111/jdv.13269
- ↑ Zhu L, Okano S, Takahara M, Chiba T, Tu Y, Oda Y, Furue M. Expression of S100 protein family members in normal skin and sweat gland tumors. J Dermatol Sci. 2013 Jun;70(3):211-9. doi: 10.1016/j.jdermsci.2013.03.002. Epub, 2013 Mar 16. PMID:23623205 doi:http://dx.doi.org/10.1016/j.jdermsci.2013.03.002
- ↑ Bertini I, Borsi V, Cerofolini L, Das Gupta S, Fragai M, Luchinat C. Solution structure and dynamics of human S100A14. J Biol Inorg Chem. 2012 Nov 30. PMID:23197251 doi:10.1007/s00775-012-0963-3
- ↑ Babini E, Bertini I, Borsi V, Calderone V, Hu X, Luchinat C, Parigi G. Structural characterization of human S100A16, a low-affinity calcium binder. J Biol Inorg Chem. 2010 Nov 3. PMID:21046186 doi:10.1007/s00775-010-0721-3

